Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
---|
03/29/2006 | EP1638984A1 Avermectin b1 monosaccharide derivatives |
03/29/2006 | EP1638549A2 Novel antibacterial agents |
03/29/2006 | EP1572707B1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
03/29/2006 | EP1256587B1 Novel pseudoerythromycin derivatives |
03/29/2006 | CN1753901A Macrolide solvates |
03/28/2006 | US7018808 Polyketides and their synthesis and use |
03/28/2006 | CA2250736C 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin a derivatives |
03/23/2006 | WO2005061524A3 Process for the preparation of form ii clarithromycin |
03/23/2006 | US20060063725 Process of preparing a crystalline azithromycin monohydrate |
03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
03/22/2006 | EP1090123B1 Polyketides and their synthesis |
03/22/2006 | CN1751049A Avermectin monosaccharide derivatives having pesticidal properties |
03/22/2006 | CN1750762A Composition containing isoflavone of high purity at high concentration and process for producing the same |
03/22/2006 | CN1749263A Several mark compounds of poacynum hendersonii woodson leaf |
03/22/2006 | CN1748740A Imature bitter orange total flavone and its preparing mthod for its preparation and quality control method |
03/22/2006 | CN1246327C Novel 8A-and 9A-15-membered lactams |
03/22/2006 | CN1246326C Pineapple flavonoid glycoside compound and its use |
03/22/2006 | CN1246316C Method for separating major monomeric compoent of soybean isoflavone |
03/21/2006 | US7015339 Washing the aqueous plant extract with a solvent, adjusting the pH from 10 to less 9, solvent extration of flavonoids |
03/21/2006 | US7015338 Synthetic methods for preparing procyanidin oligomers |
03/21/2006 | US7015203 Macrolides |
03/21/2006 | US7015201 Pyrazole derivatives and diabetic medicine containing them |
03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
03/16/2006 | US20060058248 Processes for the preparation of 6-11 bicyclic erythromycin derivatives |
03/16/2006 | US20060058246 Macrolide compounds endowed with antiinflammatory activity |
03/16/2006 | US20060058244 New pyrazole derivatives and diabetic medicine containing them |
03/15/2006 | EP1633771A1 Macrolide-conjugates with anti-inflammatory activity |
03/15/2006 | EP1633765A1 Novel 14 and 15 membered-ring compounds |
03/15/2006 | EP1633764A1 Q-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
03/15/2006 | EP1304326B1 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
03/15/2006 | CN1245361C Extracting process for epimedium total flavone |
03/14/2006 | CA2376748C Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
03/09/2006 | WO2006025051A2 Process of preparing a crystalline azithromycin monohydrate |
03/09/2006 | WO2006024405A2 Derivatives of avermectin, avermectin monosaccharide and avermectin aglycone |
03/09/2006 | US20060052441 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods |
03/08/2006 | EP1632498A1 Derivatives of avermectin, avermectin monosaccharide and avermectin aglycone |
03/08/2006 | EP1631575A1 NEW 3-DECLADINOSYL 9a-N -CARBAMOYL AND 9a-N -THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A |
03/08/2006 | EP1556397B1 9a-azalides with anti-inflammatory activity |
03/08/2006 | EP1390377B1 New crystal form of azithromycin |
03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
03/08/2006 | EP0988310B9 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
03/08/2006 | CN1744954A Biological control of nanoparticles |
03/08/2006 | CN1744887A Breast cancer-resistant protein inhibitor |
03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
03/01/2006 | EP1628990A1 Novel 14 and 15 membered ring compounds |
03/01/2006 | EP1628989A1 Novel 14 and 15 membered-ring compounds |
03/01/2006 | EP1628988A1 Novel 14 and 15 membered-ring compounds |
03/01/2006 | EP1628685A2 Antiviral phosphonate analogs |
03/01/2006 | EP1628629A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
03/01/2006 | EP1172109B1 Compositions for preventing and treating type i allergy |
03/01/2006 | CN1740185A Antitumor compound nobiliside A from Holathuria nobilis and its monoacetylated derivative |
03/01/2006 | CN1740184A Process of extracting secoiridoid glycoside product from medicinal plant gentian |
03/01/2006 | CN1243766C -’툷Á€-9-�ÐЧ-9A-Á¬ÈË-9A-©›‘ýå˜öÏAМ•·Ü´ |
03/01/2006 | CN1243765C Method for preparing hyperin and isorhamnetin-3-0-galactose glycosides reference substance simultaneously |
03/01/2006 | CN1243764C Dieneacetal peroxide glycoside kind derivative and its preparation method and its medicinal composition and use |
02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
02/23/2006 | US20060040877 Capable of functioning in Saccharopolyspora spinosa; for controlling insects |
02/23/2006 | US20060039988 Azithromycin dosage forms with reduced side effects |
02/23/2006 | CA2575737A1 Tanaproget derivatives, metabolites, and uses thereof |
02/22/2006 | EP1627883A1 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A derivatives |
02/22/2006 | CN1738828A Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4''- or 4'-position |
02/22/2006 | CN1737008A Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof |
02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
02/21/2006 | US7001742 Human uncoupling protein 3 |
02/21/2006 | CA2110401C Method for the selection of genetically transformed cells and compounds for use in the method |
02/16/2006 | WO2006017250A2 Sixteen-membered macrolide antiinfective agents |
02/16/2006 | WO2005121160A3 11, 12 cyclic thiocarbamate macrolide antibacterial agents |
02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
02/16/2006 | US20060035843 Reacting tanaproget (5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbonitrile) sodium hydride, and acetobromo- alpha -D-glucuronide acid methyl ester; non-steroidal progesterone receptor agonist; contraceptives; side effect reduction |
02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
02/16/2006 | US20060034893 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation |
02/16/2006 | US20060034774 Galactopyrannosyltriaminetetracarboxylate as ligands for bioactivated paramagnetic metal complexes |
02/15/2006 | EP1625137A1 Macrolides substituted at the 4''-position |
02/15/2006 | CN1733789A Azithromycin tartrate preparation method |
02/15/2006 | CN1733788A Method for extracting and separating silver linden glycoside from oriental paperbush flower |
02/15/2006 | CN1733785A Method for extracting chimonin |
02/15/2006 | CN1733784A Preparation method of black soybean seed capsule anthocyanin |
02/15/2006 | CN1733092A Effective ingredients of Chinese medicine moutan bark and preparation method thereof |
02/15/2006 | CN1241931C Macrolide antinfective agents |
02/15/2006 | CN1241930C Shaddock glycoside extracting and refining process from shaddock |
02/14/2006 | US6998417 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
02/14/2006 | US6998390 Oxolide antibacterials |
02/09/2006 | WO2006013409A1 Antibacterial agents |
02/09/2006 | US20060029677 Azithromycin dosage forms with reduced side effects |
02/09/2006 | DE10258007B4 Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Aromatic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
02/08/2006 | EP1622922A2 Derivatives of azithromycin |
02/08/2006 | CN1240708C New derivatives of erythromycin, process for making them and use as medicaments |
02/08/2006 | CN1240707C Z-halo-6-o-substituted ketolide derivatives |
02/08/2006 | CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole |
02/07/2006 | US6995143 Therapy against antibiotic resistance infections |
02/02/2006 | WO2006011561A1 Oligosaccharide derivative having heterocyclic ring |
02/02/2006 | US20060025357 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus |
02/02/2006 | US20060025352 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
02/02/2006 | US20060025350 4-hydroxy-2-hydroxymethyl-pyrrolidin-3-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction |
02/02/2006 | US20060025349 D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture |
02/02/2006 | US20060024345 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
02/02/2006 | DE10258008B4 Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
02/01/2006 | EP1621544A1 Remedies for diseases caused by strengthened vascular smooth muscle using 14-membered ring macrolide compounds |
02/01/2006 | CN1729200A Macrolides |